<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"
	"http://www.w3.org/TR/1998/REC-html40-19980424/loose.dtd">
<html>
<head><meta http-equiv="content-type" content="text/html; charset=UTF-8">
<style type="text/css">
 table.main {}
 tr.row {}
 td.cell {}
 div.block {}
 div.paragraph {}
 .font0 { font:6pt Arial, sans-serif; }
 .font1 { font:8pt Arial, sans-serif; }
 .font2 { font:9pt Arial, sans-serif; }
 .font3 { font:9pt Times New Roman, serif; }
 .font4 { font:10pt Times New Roman, serif; }
 .font5 { font:11pt Times New Roman, serif; }
 .font6 { font:17pt Times New Roman, serif; }

</style>
</head>
<body>
<p><span class="font1">North America Equity Research</span></p>
<p><span class="font0">05 September 2022</span></p>
<p><span class="font6">JPMorgan</span></p>
<p><span class="font0">Lisa C. Gill</span></p>
<p><span class="font0">(1-212) 622-6466</span></p>
<p><a href="mailto:lisa.c.gill@jpmorgan.com"><span class="font0">lisa.c.gill@jpmorgan.com</span></a></p>
<p><span class="font4" style="font-weight:bold;">Other Companies Discussed in This Report </span><span class="font5">(all prices in this report as of market close on 02 September 2022) Signify Health(SGFY/$28.77/OW)</span></p>
<p><span class="font4" style="font-weight:bold;">Analyst Certification: </span><span class="font4">The Research Analyst(s) denoted by an “AC” on the cover of this report certifies (or, where multiple Research Analysts are primarily responsible for this report, the Research Analyst denoted by an “AC” on the cover or within the document individually certifies, with respect to each security or issuer that the Research Analyst covers in this research) that: (1) all of the views expressed in this report accurately reflect the Research Analyst’s personal views about any and all of the subject securities or issuers; and (2) no part of any of the Research Analyst's compensation was, is, or will be directly or indirectly related to the specific recommendations or views expressed by the Research Analyst(s) in this report. For all Korea-based Research Analysts listed on the front cover, if applicable, they also certify, as per KOFI A requirements, that the Research Analyst’s analysis was made in good faith and that the views reflect the Research Analyst’s own opinion, without undue influence or intervention.</span></p>
<p><span class="font4">All authors named within this report are Research Analysts who produce independent research unless otherwise specified. In Europe, Sector Specialists (Sales and Trading) may be shown on this report as contacts but are not authors of the report or part of the Research Department.</span></p>
<p><span class="font4" style="font-weight:bold;">Important Disclosures</span></p>
<ul style="list-style:none;"><li>
<p><span class="font4" style="font-weight:bold;">• &nbsp;&nbsp;&nbsp;Market Maker/ Liquidity Provider: </span><span class="font4">J.P. Morgan is a market maker and/or liquidity provider in the financial instruments o Treia ted to CVS Health, Signify Health.</span></p></li>
<li>
<p><span class="font4" style="font-weight:bold;">• &nbsp;&nbsp;&nbsp;Manager or Co-manager: </span><span class="font4">J.P. Morgan acted as manager or co-manager in a public offering of securities or financial instruments (as such term is defined in Directive 2014/65/EU) of/for CVS Health within the past 12 months.</span></p></li>
<li>
<p><span class="font4" style="font-weight:bold;">• &nbsp;&nbsp;&nbsp;Client: </span><span class="font4">J.P. Morgan currently has, or had within the past 12 months, the following entity(ies) as clients: CVS Health, Signify Health.</span></p></li>
<li>
<p><span class="font4" style="font-weight:bold;">• &nbsp;&nbsp;&nbsp;Client/Investment Banking: </span><span class="font4">J.P. Morgan currently has, or had within the past 12 months, the following entity(ies) as investment banking clients: CVS Health.</span></p></li>
<li>
<p><span class="font4" style="font-weight:bold;">• &nbsp;&nbsp;&nbsp;Client/Non-Investment Banking, Securities-Related: </span><span class="font4">J.P. Morgan currently has, or had within the past 12 months, the following entity(ies) as clients, and the services provided were non-investment-banking, securities-related: CVS Health.</span></p></li>
<li>
<p><span class="font4" style="font-weight:bold;">• &nbsp;&nbsp;&nbsp;Client/Non-Securities-Related: </span><span class="font4">J.P. Morgan currently has, or had within the past 12 months, the following entity(ies) as clients, and the sendees provided were non-securities-related: CVS Health, Signify Health.</span></p></li>
<li>
<p><span class="font4" style="font-weight:bold;">• &nbsp;&nbsp;&nbsp;Investment Banking Compensation Received: </span><span class="font4">J.P. Morgan has received in the past 12 months compensation for investment banking sendees from CVS Health.</span></p></li>
<li>
<p><span class="font4" style="font-weight:bold;">• &nbsp;&nbsp;&nbsp;Potential Investment Banking Compensation: </span><span class="font4">J.P. Morgan expects to receive, or intends to seek, compensation for investment banking sendees in the next three months from CVS Health.</span></p></li>
<li>
<p><span class="font4" style="font-weight:bold;">• &nbsp;&nbsp;&nbsp;Non-Investment Banking Compensation Received: </span><span class="font4">J.P. Morgan has received compensation in the past 12 months for products or sendees other than investment banking from CVS Health.</span></p></li>
<li>
<p><span class="font4" style="font-weight:bold;">• &nbsp;&nbsp;&nbsp;Debt Position: </span><span class="font4">J.P. Morgan may hold a position in the debt securities of CVS Health, Signify Health, if any.</span></p></li></ul>
<p><span class="font4" style="font-weight:bold;">Company-Specific Disclosures: </span><span class="font4">Important disclosures, including price charts and credit opinion history tables, are available for compendium reports and all J.P. Morgan-covered companies, and certain non-covered companies, by visiting </span><a href="https://www.ipmm.com/research/disclosures"><span class="font3" style="text-decoration:underline;">https://www.ipmm.com/research/disclosures</span></a><span class="font3" style="text-decoration:underline;">,</span><span class="font3"> </span><span class="font4">calling 1-800-477-0406, or e-mailing </span><a href="mailto:research.disclosure.inquiries@ipmorgan.com"><span class="font3" style="text-decoration:underline;">research.disclosure.inquiries@ipmorgan.com</span></a><span class="font3"> </span><span class="font4">with your request.</span></p>
<p><span class="font0">3</span></p>
<p><span class="font2">This document is being provided for the exclusive use of TIMOTHY FINLEY at JPMorgan Chase &amp;&nbsp;Co. and clients of J.P. Morgan.</span></p>
</body>
</html>